Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE-HCC CTC-based prediction of immunotherapy efficacy in hepatocellular carcinoma
jRCT1061230098Recruiting
- Sponsor
- Tottori Prefecture
- Start
- Jan 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in hepatocellular carcinoma (HCC), sponsored by Tottori Prefecture. Started Jan 2024; status: recruiting.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCT1061230098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061230098.